PH22503A - Phenyl ethers - Google Patents

Phenyl ethers

Info

Publication number
PH22503A
PH22503A PH33996A PH33996A PH22503A PH 22503 A PH22503 A PH 22503A PH 33996 A PH33996 A PH 33996A PH 33996 A PH33996 A PH 33996A PH 22503 A PH22503 A PH 22503A
Authority
PH
Philippines
Prior art keywords
phenyl ethers
ethers
phenyl
Prior art date
Application number
PH33996A
Other languages
English (en)
Inventor
Holloway Rian Roy
Howe Ralph
Balbir Singh Rao
Stribling Donald
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of PH22503A publication Critical patent/PH22503A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
PH33996A 1985-07-30 1986-07-09 Phenyl ethers PH22503A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858519154A GB8519154D0 (en) 1985-07-30 1985-07-30 Aromatic ethers

Publications (1)

Publication Number Publication Date
PH22503A true PH22503A (en) 1988-09-12

Family

ID=10583042

Family Applications (1)

Application Number Title Priority Date Filing Date
PH33996A PH22503A (en) 1985-07-30 1986-07-09 Phenyl ethers

Country Status (27)

Country Link
US (1) US4772631A (fr)
EP (1) EP0210849B1 (fr)
JP (2) JPH0651661B2 (fr)
KR (1) KR870001142A (fr)
CN (1) CN1014516B (fr)
AR (1) AR242176A1 (fr)
AT (1) ATE55980T1 (fr)
AU (1) AU603987B2 (fr)
CA (1) CA1283122C (fr)
CS (1) CS266593B2 (fr)
DD (1) DD251551A5 (fr)
DE (1) DE3673722D1 (fr)
DK (1) DK168761B1 (fr)
ES (1) ES2002720A6 (fr)
FI (1) FI88030C (fr)
GB (1) GB8519154D0 (fr)
GR (1) GR861994B (fr)
HU (1) HUT44757A (fr)
IE (1) IE60157B1 (fr)
IL (1) IL79447A0 (fr)
NO (1) NO170480C (fr)
NZ (1) NZ217011A (fr)
PH (1) PH22503A (fr)
PL (1) PL152320B1 (fr)
PT (1) PT83085B (fr)
SU (1) SU1632370A3 (fr)
ZA (1) ZA865097B (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300290B1 (fr) * 1987-07-21 1991-12-18 F. Hoffmann-La Roche Ag Phénoxypropanolamines
GB8801306D0 (en) * 1988-01-21 1988-02-17 Ici Plc Chemical compounds
GB8905336D0 (en) * 1989-03-08 1989-04-19 Ici Plc Chemical compounds
GB8910374D0 (en) * 1989-05-05 1989-06-21 Ici Plc Chemical compounds
KR920005952B1 (ko) * 1989-05-26 1992-07-25 이사무 이와이 오수정화조의 여과재 순환 정화장치
GB8925032D0 (en) * 1989-11-06 1989-12-28 Ici Plc Chemical compounds
GB8926083D0 (en) * 1989-11-17 1990-01-10 Ici Plc Therapeutic agents
GB9003185D0 (en) * 1990-02-13 1990-04-11 Ici Plc Pharmaceutical compositions
US5245053A (en) * 1990-05-04 1993-09-14 American Cyanamid Company Substituted 5-(2-(2-aryl-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxoles
US5061727A (en) * 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
US5151439A (en) * 1990-05-04 1992-09-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
US5106867A (en) * 1990-05-04 1992-04-21 American Cyanamid Company Method of increasing lean meat in edible animals
GB9016655D0 (en) * 1990-07-30 1990-09-12 Ici Plc Therapeutic agents
GB9111425D0 (en) * 1991-05-28 1991-07-17 Ici Plc Chemical compounds
GB9111426D0 (en) * 1991-05-28 1991-07-17 Ici Plc Chemical compounds
US5502078A (en) * 1991-05-28 1996-03-26 Zeneca Limited Chemical compounds
GB9224740D0 (en) * 1992-11-26 1993-01-13 Ici Plc Therapeutic agents
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
US5488064A (en) * 1994-05-02 1996-01-30 Bristol-Myers Squibb Company Benzo 1,3 dioxole derivatives
US5491134A (en) * 1994-09-16 1996-02-13 Bristol-Myers Squibb Company Sulfonic, phosphonic or phosphiniic acid β3 agonist derivatives
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
US5770615A (en) * 1996-04-04 1998-06-23 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
US5808080A (en) * 1996-09-05 1998-09-15 Eli Lilly And Company Selective β3 adrenergic agonists
ES2171839T3 (es) 1996-09-05 2002-09-16 Lilly Co Eli Analogos de carbazol como agonistas adrenergicos selectivos de beta3.
CO5011072A1 (es) 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
GB9812709D0 (en) * 1998-06-13 1998-08-12 Glaxo Group Ltd Chemical compounds
US6344481B1 (en) 1999-03-01 2002-02-05 Pfizer Inc. Thyromimetic antiobesity agents
US7709677B2 (en) * 2001-01-31 2010-05-04 Glaxosmithkline Llc Process of preparing arylethanoldiamines
US7504435B2 (en) * 2001-01-31 2009-03-17 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method for stimulating weight loss and/or for lowering triglycerides in patients
GB0102407D0 (en) 2001-01-31 2001-03-14 Glaxo Group Ltd Process
US7202222B2 (en) * 2003-01-06 2007-04-10 National Bioscience Corporation Methods for treatment of obesity and effective fat loss promotion
AU2008219585A1 (en) * 2007-02-27 2008-09-04 The Arizona Board Of Regents On Behalf Of The University Of Arizona Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome.
US8476227B2 (en) 2010-01-22 2013-07-02 Ethicon Endo-Surgery, Inc. Methods of activating a melanocortin-4 receptor pathway in obese subjects
US9044606B2 (en) 2010-01-22 2015-06-02 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue using electrical energy
US9907767B2 (en) 2010-08-03 2018-03-06 Velicept Therapeutics, Inc. Pharmaceutical compositions and the treatment of overactive bladder
US9522129B2 (en) 2010-08-03 2016-12-20 Velicept Therapeutics, Inc. Pharmaceutical Combination
WO2013130968A1 (fr) * 2012-03-01 2013-09-06 University Of Cincinnati Composés activés par dro en tant que thérapies anti-cancer sélectives
MX2017007054A (es) 2014-12-03 2018-05-02 Velicept Therapeutics Inc Composiciones y métodos para usar solabegron de liberación modificada para sintomas del tracto urinario inferior.
US10080884B2 (en) 2014-12-29 2018-09-25 Ethicon Llc Methods and devices for activating brown adipose tissue using electrical energy
US10092738B2 (en) 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue
IL310527A (en) 2015-10-23 2024-03-01 B3Ar Therapeutics Inc Zwitterion solvegron and its uses

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1245148A (en) * 1968-11-18 1971-09-08 Pfizer Ltd Propanolamine derivatives
SE368197B (fr) * 1968-11-18 1974-06-24 Pfizer
SE354851B (fr) * 1970-02-18 1973-03-26 Haessle Ab
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
US4191765A (en) * 1976-05-25 1980-03-04 Hoechst Aktiengesellschaft 1-Aryloxy-2-hydroxy-3-aminopropanes
CH632987A5 (en) * 1976-10-07 1982-11-15 Haessle Ab Process for preparing novel amines
SE416545B (sv) * 1976-10-07 1981-01-19 Haessle Ab Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat
EP0006735B1 (fr) * 1978-06-28 1983-06-15 Beecham Group Plc Amines secondaires, procédé pour leur préparation, compositions pharmaceutiques les contenant et leur utilisation
SE7807408L (sv) * 1978-06-30 1979-12-31 Haessle Ab Hjertaktiva foreningar
DE3061334D1 (en) * 1979-06-16 1983-01-20 Beecham Group Plc Ethanamine derivatives, their preparation and use in pharmaceutical compositions
ATE2265T1 (de) * 1979-10-25 1983-02-15 Beecham Group Plc Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
IL65541A0 (en) * 1981-05-06 1982-07-30 Haessle Ab Alkylamino-2-propanols,process for their preparation and pharmaceutical preparations containing same
GB8415377D0 (en) * 1984-06-15 1984-07-18 Beecham Group Plc Compounds
GB8510146D0 (en) * 1985-04-20 1985-05-30 Smith Kline French Lab Chemical compounds & processes

Also Published As

Publication number Publication date
EP0210849B1 (fr) 1990-08-29
AU603987B2 (en) 1990-12-06
FI862896A (fi) 1987-01-31
AR242176A1 (es) 1993-03-31
PT83085A (en) 1986-08-01
NZ217011A (en) 1990-02-26
GR861994B (en) 1986-11-26
NO863061D0 (no) 1986-07-29
CA1283122C (fr) 1991-04-16
JPS6277357A (ja) 1987-04-09
EP0210849A1 (fr) 1987-02-04
NO170480B (no) 1992-07-13
IE60157B1 (en) 1994-06-15
CN1014516B (zh) 1991-10-30
FI88030B (fi) 1992-12-15
ZA865097B (en) 1987-03-25
IL79447A0 (en) 1986-10-31
HUT44757A (en) 1988-04-28
NO863061L (no) 1987-02-02
ATE55980T1 (de) 1990-09-15
KR870001142A (ko) 1987-03-11
GB8519154D0 (en) 1985-09-04
CS573586A2 (en) 1989-04-14
PL152320B1 (en) 1990-12-31
ES2002720A6 (es) 1988-10-01
DD251551A5 (de) 1987-11-18
DE3673722D1 (en) 1990-10-04
IE861827L (en) 1987-01-30
AU6002986A (en) 1987-02-05
DK359986D0 (da) 1986-07-29
PL260759A1 (en) 1988-09-15
PT83085B (pt) 1989-01-30
DK168761B1 (da) 1994-06-06
SU1632370A3 (ru) 1991-02-28
JPH0651661B2 (ja) 1994-07-06
JPH0819062B2 (ja) 1996-02-28
JPH06340597A (ja) 1994-12-13
CS266593B2 (en) 1990-01-12
CN86105400A (zh) 1987-03-11
FI88030C (fi) 1993-03-25
DK359986A (da) 1987-01-31
NO170480C (no) 1992-10-21
US4772631A (en) 1988-09-20
FI862896A0 (fi) 1986-07-09

Similar Documents

Publication Publication Date Title
PH22503A (en) Phenyl ethers
GB2178739B (en) Insecticidal ethers
GB8509348D0 (en) Ethers
NZ215263A (en) Silylenol ethers
GB8609821D0 (en) Cyclopentyl ethers
GB8615743D0 (en) 5 6-epoxy-7-oxabicycloheptane substituted ethers
GB8616586D0 (en) Phenyl ethers
GB2172279B (en) Pyroeletric ceramics
ZA853550B (en) Azolylvinyl ethers
ZA863194B (en) Substituted azolylmethyl ethers
GB8511893D0 (en) Ethers
GB8525456D0 (en) Arylglycidyl ethers
PH22761A (en) Novel 4-acylresorcinol ethers
IE843342L (en) (3-hydroxy-4-alkoxy)phenyl esters- sweeteners
GB8900385D0 (en) Insecticidal ethers
DE3573117D1 (en) Resorcinol ethers
IE843202L (en) Phenyl alkyl ethers
IE851902L (en) Fragrant ethers
IE851167L (en) Cyclic azovinyl ethers
IE852807L (en) Resorcinol ethers
IE851294L (en) Resorcinol ethers
IL76995A0 (en) Further novel resorcinol ethers
ZA858772B (en) Further novel resorcinol ethers
GB8527662D0 (en) Cylic ethers
GB8519477D0 (en) Slide mount